Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac and lidocaine for pain relief during IUD insertion
NCT02332057Phase 2
Key facts
- Status
- Completed
- Start
- Feb 2015
- Primary completion
- Sep 2015
- Countries
- 1
- Sponsor
- Cairo University
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Conditions
- pain
01
Overview
Phase 2, randomised, double-blind trial of diclofenac and lidocaine 10% oropharyngeal spray in pain, sponsored by Cairo University. Primary endpoint: Visual Analogue Scale at 3 months. Started Feb 2015; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Women of reproductive age requesting IUD for contraception, excluding those with IUD contraindications (e.g., pregnancy, PID, uterine anomalies), previous IUD insertion, or allergies to diclofenac or lidocaine.
04
Endpoints
Primary
Visual Analogue Scale
Secondary
Adverse effects
Beyond the preview
Go deeper on NCT02332057.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332057.